Explore the Fingerprint Trends
Explore the Research Network
This is a list of publications by this organization, listed chronologically starting with the most recent first. The source of publications may be a combination of Scopus and manually entered data from a user. New publications from Scopus appear in this list weekly and publications entered by a user appear instantly. Citation counts start from 1996 and come directly from Scopus.
Marilyn J. Telen; Araba Afenyi-Annan; Melanie E. Garrett; Martha R. Combs; Eugene P. Orringer; Allison E. Ashley-Koch
Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival
Gowthami M. Arepally; Thomas L. Ortel
Changing practice of anticoagulation: Will target-specific anticoagulants replace warfarin?
Marie E. Steiner; Paul M. Ness; Susan F. Assmann; Darrell J. Triulzi; Steven R. Sloan; Meghan Delaney; Suzanne Granger; Elliott Bennett-Guerrero; Morris A. Blajchman; Vincent Scavo; et al.
Effects of red-cell storage duration on patients undergoing cardiac surgery
Srdan Verstovsek; Ruben A. Mesa; Jason Gotlib; Richard S. Levy; Vikas Gupta; John F. Dipersio; John V. Catalano; Michael W. N. Deininger; Carole B. Miller; Richard T. Silver; et al.
Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: Results of a median 3-year follow-up of COMFORT-I
Brady L. Stein; Jason Gotlib; Murat Arcasoy; Marie Huong Nguyen; Neil Shah; Alison Moliterno; Catriona Jamieson; Daniel A. Pollyea; Bart Scott; Martha Wadleigh; et al.
Historical views, conventional approaches, and evolving management strategies for myeloproliferative neoplasms
Tsin W. Yeo; Daniel A. Lampah; Enny Kenangalem; Emiliana Tjitra; Ric N. Price; J. Brice Weinberg; Keith Hyland; Donald L. Granger; Nicholas M. Anstey
Impaired Systemic Tetrahydrobiopterin Bioavailability and Increased Dihydrobiopterin in Adult Falciparum Malaria: Association with Disease Severity, Impaired Microvascular Function and Increased Endothelial Activation
Matthew P. Rubach; Jackson Mukemba; Salvatore Florence; Bert K. Lopansri; Keith Hyland; Alicia D. Volkheimer; Tsin W. Yeo; Nicholas M. Anstey; J. Brice Weinberg; Esther D. Mwaikambo; et al.
Impaired Systemic Tetrahydrobiopterin Bioavailability and Increased Oxidized Biopterins in Pediatric Falciparum Malaria: Association with Disease Severity
A. Rabinovich; J.M. Cohen; M. Cushman; P.S. Wells; M.A. Rodger; M.J. Kovacs; D.R. Anderson; V. Tagalakis; A. Lazo-Langner; S. Solymoss; et al.
Inflammation markers and their trajectories after deep vein thrombosis in relation to risk of post-thrombotic syndrome
Ian Welsby; Thomas L. Ortel
Is it time for individualized thromboprophylaxis regimens in the ICU?
Wei Jiang; Stephen H. Boyle; Thomas L. Ortel; Zainab Samad; Eric J. Velazquez; Robert W. Harrison; Jennifer Wilson; Cynthia Kuhn; Redford B. Williams; Christopher M. O'Connor; et al.
Platelet aggregation and mental stress induced myocardial ischemia: Results from the Responses of Myocardial Ischemia to Escitalopram Treatment (REMIT) study
Marilyn J. Telen; Ted Wun; Timothy L. McCavit; Laura M. De Castro; Lakshmanan Krishnamurti; Sophie Lanzkron; Lewis L. Hsu; Wally R. Smith; Seungshin Rhee; John L. Magnani; et al.
Randomized phase 2 study of GMI-1070 in SCD: Reduction in time to resolution of vaso-occlusive events and decreased opioid use
S. Schulman; M. Zondag; L. Linkins; S. Pasca; Y.W. Cheung; M. de Sancho; A. Gallus; R. Lecumberri; S. Molnar; W. Ageno; et al.
Recurrent venous thromboembolism in anticoagulated patients with cancer: Management and short-term prognosis
Hussain R. Yusuf; W. Craig Hooper; Scott D. Grosse; Christopher S. Parker; Sheree L. Boulet; Thomas L. Ortel
Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: A study among a U.S. cohort of commercial insurance enrollees
Grace Lee; Murat O. Arcasoy
The clinical and laboratory evaluation of the patient with erythrocytosis
C.W. Francis; C.M. Kessler; S.Z. Goldhaber; M.J. Kovacs; M. Monreal; M.V. Huisman; D. Bergqvist; A.G. Turpie; T.L. Ortel; A.C. Spyropoulos; et al.
Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: The DALTECAN Study
Deborah A. Lewis; Sunil Suchindran; Michele G. Beckman; W. Craig Hooper; Althea M. Grant; John A. Heit; Marilyn Manco-Johnson; Stephan Moll; Claire S. Philipp; Kristy Kenney; et al.
Whole blood gene expression profiles distinguish clinical phenotypes of venous thromboembolism
Tsin W. Yeo; Daniel A. Lampah; Enny Kenangalem; Emiliana Tjitra; J. Brice Weinberg; Donald L. Granger; Ric N. Price; Nicholas M. Anstey
Decreased endothelial nitric oxide bioavailability, impaired microvascular function, and increased tissue oxygen consumption in children with falciparum malaria
MEK inhibitors, novel anti-adhesive molecules, reduce sickle red blood cell adhesion in vitro and in vivo, and vasoocclusion in vivo
T. Wun; L. Styles; L. DeCastro; M.J. Telen; F. Kuypers
Phase 1 study of the E-selectin inhibitor GMI 1070 in patients with sickle cell anemia (PLoS ONE (2014) 9, 7 (e101301) DOI:10.1371/journal.pone.0101301)
Zainab Samad; Stephen Boyle; Mads Ersboll; Amit N. Vora; Ye Zhang; Richard C. Becker; Redford Williams; Cynthia Kuhn; Thomas L. Ortel; Joseph G. Rogers; et al.
Sex differences in platelet reactivity and cardiovascular and psychological response to mental stress in patients with stable ischemic heart disease: Insights from the REMIT study